News
11-10-2016, 05:30 AM
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company’s breast cancer recurrence assay, MammaPrint, in the Middle East.
More... (http://www.news-medical.net/news/20161110/Agendia-partners-with-Cryogene-and-Mist-to-distribute-breast-cancer-recurrence-assay-in-the-Middle-East.aspx)
More... (http://www.news-medical.net/news/20161110/Agendia-partners-with-Cryogene-and-Mist-to-distribute-breast-cancer-recurrence-assay-in-the-Middle-East.aspx)